SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
魅雪霓
Lv1
30 积分
2021-07-28 加入
最近求助
最近应助
互助留言
Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin
1年前
已完结
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
1年前
已完结
Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial
1年前
已完结
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases
1年前
已完结
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer
1年前
已完结
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study
1年前
已完结
Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers
1年前
已完结
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
1年前
已完结
Host immunomodulatory lipids created by symbionts from dietary amino acids
2年前
已完结
没有进行任何应助
内容与标题不符合
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论